Abstract:Background Oct4 and Nanog are key regulatory genes that maintain the pluripotency and self-renewal properties of embryonic stem cells. We previously reported that the two stemness markers were tightly associated with cancer progression and poor outcomes of hepatocellular carcinoma. In this study, we demonstrate that coexpression of Oct4/Nanog modulates activation of signal transducer and activator of transcription 3 (Stat3), an oncogenic transcription factor that is activated in many human malignancies including hepatocellular carcinoma (HCC), as well as the expression of Snail, a key regulator implicated in epithelial-mesenchymal transition and tumor metastasis. Methods Oct4 and Nanog were ectopic expressed in MHCC97-L cell lines via lentiviral gene transfection. The stemness characteristics including self-renewal, proliferation, chemoresistance, and tumorigenicity were assessed. The effect of coexpression of Oct4 and Nanog on epithelial-mesenchymal transition change, and the underlying molecular signaling was investigated. Results Ectopic coexpression of Oct4 and Nanog empowered MHCC97-L cells with cancer stem cell (CSC) properties, including self-renewal, extensive proliferation, drug resistance, and high tumorigenic capacity. Significantly, Oct4 and Nanog encouraged epithelial-mesenchymal transition change contributing to tumor migration, invasion/metastasis in vitro and in vivo . Following molecular mechanism investigation indicated Oct4/Nanog-regulated epithelial-mesenchymal transition change through Stat3-dependent Snail activation. Moreover, silencing Stat3 abrogates Oct4/Nanog-mediated epithelial-mesenchymal transition (EMT) change and invasion/metastasis in HCC. Conclusions We delineate Oct4 and Nanog initiate stem cell characteristics in hepatocellular carcinoma and promote epithelial-mesenchymal transition through activation of Stat3/Snail signaling. Our findings propose Stat3/Snail pathway as a novel therapeutic target for the treatment of progression and metastasis of HCC with CSC-like signatures and epithelial-mesenchymal transition phenotype.

Oct4 Induces EMT Through LEF1/β-catenin Dependent WNT Signaling Pathway in Hepatocellular Carcinoma.

Polycomb Protein Ezh2 Activates Wnt/Beta-Catenin Signaling To Promote Hepatocellular Carcinoma Development

[OCT4 Expression in Hepatocellular Carcinoma and Its Clinical Significance].

Transcription factor AP-4 promotes tumorigenic capability and activates the Wnt/β-catenin pathway in hepatocellular carcinoma

OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma

Multiple Novel Hepatocellular Carcinoma Signature Genes Are Commonly Controlled by the Master Pluripotency Factor OCT4.

Author Correction: Integrin Β4 Promotes Cell Invasion and Epithelial-Mesenchymal Transition Through the Modulation of Slug Expression in Hepatocellular Carcinoma

Coexpression of Gene Oct4 and Nanog Initiates Stem Cell Characteristics in Hepatocellular Carcinoma and Promotes Epithelial-Mesenchymal Transition Through Activation of Stat3/Snail Signaling

Oct4 Promoted Proliferation, Migration, Invasion, and Epithelial-Mesenchymal Transition (EMT) in Colon Cancer Cells by Activating the SCF/c-Kit Signaling Pathway

The emerging roles of Oct 4 in tumor-initiating cells

Double-negative Feedback Loop Between Wnt/β-catenin Signaling and HNF4α Regulates Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma

The Emerging Roles of Oct4 in Tumor-Initiating Cells.

Octamer 4/microrna‐1246 Signaling Axis Drives Wnt/β‐catenin Activation in Liver Cancer Stem Cells

OCT 4 expression in hepatocellular carcinoma and its clinical significance

Lymphoid Enhancer-Binding Factor-1 Promotes Stemness and Poor Differentiation of Hepatocellular Carcinoma by Directly Activating the NOTCH Pathway

Aberrant Expression and Function of TCF4 in the Proliferation of Hepatocellular Carcinoma Cell Line BEL-7402

TM4SF1 upregulates MYH9 to activate the NOTCH pathway to promote cancer stemness and lenvatinib resistance in HCC

LAPTM4B-mediated hepatocellular carcinoma stem cell proliferation and MDSC migration: implications for HCC progression and sensitivity to PD-L1 monoclonal antibody therapy

Hepatocyte Nuclear Factor 4 Alpha Suppresses the Development of Hepatocellular Carcinoma

Oct4 Regulates the Transition of Cancer Stem-Like Cells to Tumor Endothelial-Like Cells in Human Liver Cancer

Octamer-binding protein 4 affects the cell biology and phenotypic transition of lung cancer cells involving β-catenin/E-cadherin complex degradation.